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Abstract
Background: The respiratory tract of swine is colonized by several bacteria among which are threeMycoplasma
species:Mycoplasma flocculare,Mycoplasma hyopneumoniae andMycoplasma hyorhinis. While colonization byM.
flocculare is virtually asymptomatic,M. hyopneumoniae is the causative agent of enzootic pneumonia andM. hyorhinis
is present in cases of pneumonia, polyserositis and arthritis. The genomic resemblance among these three
Mycoplasma species combined with their different levels of pathogenicity is an indication that they have unknown
mechanisms of virulence and differential expression, as for most mycoplasmas.
Methods: In this work, we performed whole-genome metabolic network reconstructions for these three
mycoplasmas. Cultivation tests and metabolomic experiments through nuclear magnetic resonance spectroscopy
(NMR) were also performed to acquire experimental data and further refine the models reconstructed in silico.
Results: Even though the refined models have similar metabolic capabilities, interesting differences include a wider
range of carbohydrate uptake inM. hyorhinis, which in turn may also explain why this species is a widely contaminant
in cell cultures. In addition, the myo-inositol catabolism is exclusive toM. hyopneumoniae and may be an important
trait for virulence. However, the most important difference seems to be related to glycerol conversion to
dihydroxyacetone-phosphate, which produces toxic hydrogen peroxide. This activity, missing only inM. flocculare,
may be directly involved in cytotoxicity, as already described for two lung pathogenic mycoplasmas, namely
Mycoplasma pneumoniae in human andMycoplasmamycoides subsp.mycoides in ruminants. Metabolomic data
suggest that even though these mycoplasmas are extremely similar in terms of genome and metabolism, distinct
products and reaction rates may be the result of differential expression throughout the species.
Conclusions: We were able to infer from the reconstructed networks that the lack of pathogenicity ofM. flocculare if
compared to the highly pathogenicM. hyopneumoniaemay be related to its incapacity to produce cytotoxic
hydrogen peroxide. Moreover, the ability ofM. hyorhinis to grow in diverse sites and even in different hosts may be a
reflection of its enhanced and wider carbohydrate uptake. Altogether, the metabolic differences highlighted in silico
and in vitro provide important insights to the different levels of pathogenicity observed in each of the studied species.
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Background
The respiratory tract of swine is colonized by several
bacteria, among which are three common Mycoplasma
species: Mycoplasma flocculare, Mycoplasma hyopneu-
moniae, and Mycoplasma hyorhinis [1–3]. Even though
little information is available concerning the prevalence of
bacteria in healthy lungs, these threeMycoplasma species
have been isolated from the respiratory tract of both
healthy and diseased pigs [4–6].
While M. flocculare is usually described as a commen-
sal bacterium [7],M. hyopneumoniae andM. hyorhinis are
considered pathogenic. Enzootic pneumonia, caused by
M. hyopneumoniae, is widespread in pig populations and
is considered a major cause of economic loss in the pig
industry [8]; M. hyorhinis is frequently present in cases
of polyserositis and arthritis and M. flocculare has high
prevalence in swine herds worldwide, but up to date, no
disease has been per se associated with this species [7].
In addition to these mycoplasmas, Mycoplasma hyosyn-
oviae, the primary agent of non-purulent arthritis, can
occasionally colonize in the lower respiratory tract when
pneumonic lesions pre-exist [9].
Besides mycoplasmal pneumonia, the Porcine Respira-
tory Disease Complex (PRDC) has emerged as an eco-
nomically signigicant respiratory disorder characterized
by the slow growth, fever, cough, loss of appetite, lethargy
and dyspnea in pigs [10, 11]. Even thoughmany species are
related to PRDC, it is essential to note that enzootic pneu-
monia caused by M. hyopneumoniae is by far the most
costly disease in pig industry, and this bacteria is usually
seen as an essential component to the successful establish-
ment of a pathogenic community in the host [12]. Also,M.
hyopneumoniae infections take longer to cause lesions and
to be successfully eliminated than infections from other
pathogens [10].
While mycoplasmal diseases in swine have been exten-
sively studied, their causative agents have not been
explored from a mathematical and computational point
of view, mostly because their genome sequences were
not available until recently [13–21]. Although recent
studies have placed M. hyopneumoniae, M. flocculare
and M. hyorhinis in close proximity within the hyop-
neumoniae clade by phylogenomic analysis [18], which
corroborates with their high 16S rRNA sequence sim-
ilarity [22], it is not yet clear what causes the specific
pathogenicity or lack thereof in each of them. This ele-
vated genomic resemblance combined with their different
levels of pathogenicity is an indication that these species,
as for most mycoplasmas, have unknown mechanisms of
virulence and differential expression.
Pathogenic determinants such as adhesion to the host
cell and evasion from the immune response have already
been well-described in the literature for both M. hyop-
neumoniae and M. hyorhinis [23–27]. The presence of
a capsule in M. hyopneumoniae has been reported to
be important for the interaction with the host cells in
one single study [28]. Several studies also show that
immunosuppressed animals experimentally infected with
Mycoplasma species develop less severe microscopic
lesions of pneumonia if compared to normal animals
[29–31]. This means that it is possible in some cases that
a strong response from the host immune system might be
the primary cause of pathogenesis. However, up to date, it
is not possible to draw any further conclusions due to lack
of experimental data.
Even if these topics are of utter importance for under-
standing swine respiratory tract mycoplasmal diseases,
what has yet to be better understood is the direct par-
ticipation of metabolism in the development of them.
For instance, although adhesion factors are related to
pathogenicity, M. hyopneumoniae and M. flocculare har-
bor similar sets of adhesion proteins [32], and have been
shown to adhere to cilia in a similar way [33]. Thus, the
ability ofM. hyopneumoniae to cause disease if compared
toM. floccularemight not be directly related to adhesion.
Furthermore, the genome sizes of Mycoplasma spp.
range from 580 kb (Mycoplasma genitalium) to more
than 1,358 kb (Mycoplasma penetrans), representing an
important example of genome reduction (and minimal
metabolism) during the evolutionary process. It is possi-
ble that in an initial symbiotic phase, the host provided
a broad range of metabolites for these bacteria. This,
together with the ability of the bacteria to uptake such
compounds, made several activities dispensable for the
bacterial life. Over the course of evolution, these bacteria
would have lost some of the genes that became unnec-
essary for life in an environment conditioned by another
genome [34].
In this way, we aimed at studying the reduced
metabolism through genome-scale metabolic model
reconstructions of M. hyopneumoniae, M. hyorhinis and
M. flocculare to better understand their different life-
styles. Based on the reconstructed networks, we propose
that one of the mechanisms that may explain why M.
hyorhinis and M. hyopneumoniae are pathogenic while
M. flocculare is not, is their ability to use glycerol as
a carbon source, thus enabling the production of the
highly toxic hydrogen peroxide. This trait may be directly
involved in cytotoxicity, as already described for two lung
pathogenic mycoplasmas, namely Mycoplasma pneumo-
niae in human [35] and Mycoplasma mycoides subsp.
mycoides in ruminants [36].
Additionally, growth rates and fitness have been corre-
lated in the past to virulence in several other organisms
[37–39] and may be a key factor for the difference in
pathogenicity among these three mycoplasmas. Indeed,
the in silico models show that M. hyorhinis and M. hyop-
neumoniae have extra sets of enzymes that may help
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them overgrow the non-pathogenic speciesM. flocculare.
M. hyorhinis seems to have a wider carbohydrate uptake
range, and probably for this reason is seen as a well-known
contaminant of cell cultures [40]. M. hyopneumoniae, on
the other hand, might use myo-inositol as a carbon source
producing acetyl-coenzyme-A as a byproduct. This fea-
ture is of particular interest for the production of cofactor
Coenzyme-A in this species, since most enzymes from the
biosynthetic pathway are missing in all species.
Nevertheless, there is little metabolic experimental data
available for the three species, which makes the recon-
struction of a reliable metabolic model an extremely
time-consuming work. Together with the fact that these
mycoplasmas are generally grown in complex media, with
high serum concentrations, we needed additional experi-
mental data in order to compare the in silico reconstructed
metabolic networks with the in vivo metabolic character-
istics of the three species. For this reason, we also per-
formed nuclear magnetic resonance spectroscopy (NMR)
analyses to detect metabolites consumed and produced in
both complex and defined media. These experiments cor-
roborated with the reconstructed models and suggested
two new features in particular: (i) the uptake of myo-
inositol inM. hyopneumoniaemight be related to a higher
acetate production, and (ii)M. hyorhinis showed a surpris-
ingly reduced ability to convert pyruvate to acetate in the
growth conditions used in this study. All these in silico and
in vivo metabolic differences might influence the different
levels of pathogenicity in each of the species studied here.
We present in this work the metabolic networks
reconstructed from the annotated genomes of the three
species and the comparison done with growth rates and
metabolomic experiments performed in vitro in order to
better understand the basis of the pathologies caused by
these bacteria, which might help prevent their develop-
ment in the future.
Methods
Modeling methods
Network reconstruction and refinement
We reconstructed the metabolic networks for all avail-
able strains isolated from swine so far of M. hyopneu-
moniae (pathogenic strains 232, 7422, 7448, 168 and
non-pathogenic strains J and 168L), M. hyorhinis (HUB-
1, GDL-1, SK-76 and ATCC 17981 strain BTS7) and M.
flocculare (ATCC 27716 and ATCC 27399). The semi-
automated reconstructions were generated by the Patho-
logic tool from the Pathway Tools software [41] using
the complete genomes available online. From now on, the
species strains will be abbreviated according to Table 1.
Pathway Tools automatically associated genes with reac-
tions, based on the annotation names, Gene Ontology
(GO) terms and enzyme code (EC) numbers contained in
the GenBank files. The software assembled reactions into
pathways by comparing them with the reference database,
MetaCyc. The software automatically added missing reac-
tions from the reference database to the model, creating
many orphan reactions (reactions that do not have an
enzyme associated). In a gapfilling step, we used the Path-
way Hole Filler tool, included in the Pathway Tools soft-
ware, to identify possible candidate genes associated with
these orphan reactions. Orphan reactions in themetabolic
network were allowed only to allow known functionalities
of the organisms or biomass production in the recon-
structed models. We incorporated the minimal number
of orphan reactions into the models to avoid adding a
behavior that was never described.
In our work, the refinement of the networks was made
in a subsystems approach [42] simultaneously on all
organisms. As a result of different genomic annotations,
slightly different reactions arose throughout the automatic
models. These reactions were checked for consistency,
and after validation of only one of them, the duplicates
were deleted. Gene-Protein-Reaction (GPR) associations
were systematically validated or included based on experi-
mental data, information provided by the Pfam functional
domain database [43], synteny analysis (gene context) and
reciprocal sequence homology (BLASTp) searches, using
at first high E-value cutoffs of at least 10−10 [44]. When-
ever no hits were achieved with these parameters, more
relaxed parameters were assumed (E-value cutoffs of at
least 10−5). Homolog proteins with equivalent functional
domains were assigned as isozymes to a particular reac-
tion, while proteins with distinct functional domains were
assigned as subunits of a multi-protein complex.
Non-metabolic reactions such as DNA polymeriza-
tion, protein synthesis and RNA synthesis were explicitly
deleted from the network but implicitly included in the
biomass assembly. Generic reactions were either specified
or excluded from the models. The resulting models were
further refined in accordance with a detailed protocol
from Palsson and Thiele [45]. Reactions were compu-
tationally balanced for mass and charge, while cofactor
usage was determined based on literature data for closely
related species [46–48] . Reaction directionality was
thermodynamically checked and validated. Reaction direc-
tionality was determined based on the component contri-
bution method [49, 50], which extends the group contrib
ution method [51] and achieves a significant improvement
in the accuracy of the estimations of standard Gibbs ener-
gies. An online search and calculation interface called
eQuilibrator along with metabolite and reaction thermo-
dynamic databases are available at [52, 53]. Heuristic rules
were used to improve the directionality assignment.
We analyzed the network topology to identify com-
pounds that were only produced or consumed in the net-
work, the so-called dead-end metabolites (DEM). When-
ever a DEM was found, we either (i) added or validated
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Table 1 Selected species and strains, abbreviation, NCBI accession numbers and experimental availability of strains
Species Strain Accession number Abbreviation Pathogenicity level Experimental availability a Reference
M. hyopneumoniae 168 NC_017509 MHP_168 Pathogenic NA [16]
168L CP003131 MHP_168L Attenuated NA [19]
232 AE017332 MHP_232 Pathogenic NA [13]
7422 NC_021831 MHP_7422 Pathogenic Brazil [18]
7448 AE017244 MHP_7448 Pathogenic Brazil [14]
J AE017243 MHP_J Attenuated Brazil and France [14]
All Strains NA MHP NA NA NA
M. hyorhinis HUB-1 NC_014448 MHR_HUB1 Pathogenic NA [15]
GDL-1 NC_016829 MHR_GDL1 NAb NA [17]
SK-76 NC_019552 MHR_SK76 Pathogenic NA [20]
ATCC 17981 ARTL0100000 MHR_17981 Attenuated Brazil and France NA c
All Strains NA MHR NA NA NA
M. flocculare ATCC 27399 CP007585 MFL_27399 Commensal France [21]
ATCC 27716 AFCG01000000 MFL_27716 Commensal Brazil [18]
All Strains NA MFL NA NA NA
Notes:
NA: Not available
a : Strains available only in Brazil are protected strains which are property of the government and cannot be used outside authorised laboratories. Strains available in France
were purchased from the ATCC repository; these strains were also available for testing in the laboratory in Brazil
b :M. hyorhinis strain GDL-1 was retrieved from a contaminated cell line and, to our knowledge it has never been reported neither as pathogenic nor as an attenuated strain
c :M. hyorhinis strain ATCC 17981 genome is available online but not published in any paper up to now. (source: http://genomeportal.jgi.doe.gov/Mychy1/Mychy1.info.html)
an orphan reaction to reconnect it to the rest of the net-
work, or (ii) removed the reaction from the model when
both substrate(s) and product(s) were disconnected from
the network and/or did not affect the overall metabolism.
Transporters were predicted at first from genome anno-
tation using the Transport Identification Parser, from
Pathway Tools [54]. Transporters were predicted mainly
based on sequence similarity to other known transporters,
since experimental data for the three mycoplasmas were
not available. Specific transport reactions and exchange
reactions required for production of biomass compo-
nents were manually added to the final version of the
networks.
Biomass composition and biomass equation
In order to simulate growth, we had first to estimate the
average cell composition of these mycoplasmas (biomass
composition). To this end, we used a general macro-
molecule mycoplasma cell composition from Razin and
collaborators [55]. Depending on the species, the authors
showed that the solid residue contained 54–62 % of
proteins, 12–20 % of lipids, 3–8 % of carbohydrates,
8–17 % of RNA, and 4–7 % of DNA. Themembranes com-
prised around 35 % of dry weight of the organisms and
contained 47–60 % of proteins, 35–37 % lipids, 4–7 % car-
bohydrates and small amounts of DNA and RNA. Since
no information on metal ions and cofactors was available,
we included them quantitatively based on the metabolic
networks reconstructed for related mycoplasmas [46, 47].
Membrane and lipid components were added based on lit-
erature composition of the selected species. It is important
to note that the only difference in composition between
the species reported so far was related to the presence of
glycolipids inM. hyopneumoniae andM. flocculare, which
were reported to be absent inM. hyorhinis [56–58]. Based
on the previous information, we assumed the following
fractions of macromolecules: 55 % proteins, 15 % lipids,
6.88 % carbohydrates, 12 % RNA, 6 % DNA, and 5.12 %
of ions and cofactors. To create a biomass elemental for-
mula, we took into account the percentage contribution of
each of the components to the overall cell. The biomass
reaction represented the drain of these components into
biomass production. It implicitly assembled DNA repli-
cation, RNA transcription, and protein synthesis into one
single reaction. Amino acids were indirectly included in
the biomass reaction: charged tRNAs were accounted as
substrates and uncharged tRNAs as products. Growth and
non-growth associated maintenance (GAM and NGAM)
were estimated based on the literature and were manually
added to the models [59, 60]. The details for the com-
plete assembly of the biomass reaction can be found in
Additional file 2.
Ferrarini et al. BMC Genomics  (2016) 17:353 Page 5 of 20
Model validation and FBA analysis
The metabolic networks were exported as a mathematical
Systems Biology Markup Language (SBML) models [61].
They were uploaded to the COBRA-toolbox v2.0 Mat-
lab extension [62] for Flux Balance Analysis (FBA) test-
ing. Minimum-maximum flux constraints were imposed
based on literature information [46]. Growth simulations




Complex media comprised (i) Friis media [63] (avail-
able in Brazil), and (ii) a commercial mycoplasma broth
(provided by Indicia Biotechnology, available in France).
Defined media cultivation tests were performed in France
and comprised (i) a medium described for M. pneumo-
niae strain 129 by Yus and collaborators (2009), and (ii)
commercial media CMRL with no glutathione (Invitro-
gen). Since we had no information onmetabolism of swine
mycoplasmas, we decided to supplement the defined Yus
medium with all amino acids (from now on the sup-
plemented version will be referred to as Yus+). We also
supplemented the CMRL-1066 medium with other pep-
tone and/or other cofactors (from now on these will
be referred to as CMRL+ and CMRL+/Pep). Informa-
tion on the composition of all defined media is available
in Additional file 1: Table S1. Cells were cultivated at
37 °C for different time periods, under gentle agitation
(100 rpm).
Cell concentration estimation and viability by color changing
units (CCU)measurement
Cell growth and viability was measured with triplicate
time-matched samples of cells and culture media for CCU
as described by Stemke and Robertson [64]. Viability of
cells is visible by a change in medium color from red to
yellow. For cell concentration measurements, the cultures
were subjected to a series of 10-fold dilutions in complex
media and 1 CCU/mL was defined as the highest dilution
of cells able to change the medium color [65].
Samples for NMR spectroscopy
NMR was performed with complex Friis medium
(with strains MHP_7448, MHP_J, MHR_17981 and
MFL_27716) and defined Yus+ medium (with strains
MHP_J, MHR_17981 and MFL_27716). The medium was
collected at the following time intervals: 0 h, 8 h, 10 h,
24 h, 32 h, and 48 h for Friis medium and 0 h, 8 h, 24 h,
32 h, 48 h, 56 h and 72 h for Yus+ medium. Cells were
separated from growth media through sedimentation at
3360 g for NMR analysis. Samples consisted of biological
triplicates in complex medium and biological duplicates
in defined medium. Since we had slight different time
intervals, care was taken by not directly comparing the
results from different experiments.
NMR analysis
Sample preparation was as follows: 60 μL of a mixture
containing 1.25MKH2PO4 phosphate buffer (pH=7,4) in
D2O with 2mMNaN3 and 0.1 % trimethylsilyl propionate
(TMSP) was added to 540 μL supernatant samples. Both
solutions were mixed thoroughly and 550 μL were then
transferred to 5 mm NMR tubes and sorted in 96-tubes
racks.
All NMR experiments were carried out on a Bruker
800 MHz NMR spectrometer equipped with a 5 mm
TXI probe and a SampleJet autosampler, enabling high-
throughput data acquisition for large collections of sam-
ples. The temperature was controlled at 27 °C throughout
the experiments, and the samples were kept refrigerated at
4 °C during a waiting time of less than 24 h in the autosam-
pler, before the NMR analysis. Standard 1H 1D NMR
pulse sequence nuclear Overhauser effect spectroscopy
(NOESY) with z-gradient and Carr-Purcell-Meiboom-Gill
(CPMG) with water presaturation (Bruker pulse program
noesygppr1d and cpmgpr1d) were applied on each sample
to obtain the corresponding metabolic profiles. A total of
128 transient free induction decays (FID) were collected
for each experiment with a spectral width of 20 ppm. The
relaxation delay was set to 4 s. The NOESY mixing time
was set to 10 ms. The total acquisition time of each sam-
ple was 12 min 34 s. The CPMG spin-echo delay was set
to 300 ms, for a total filter of 77 ms, allowing an efficient
attenuation of the lipid and protein NMR signals. The 90°
pulse length was automatically calibrated for each sample
at around 10 μs.
Data processing: All FIDs were multiplied by an
exponential function corresponding to a 0.3 Hz line-
broadening factor, prior Fourier transformation. 1H-NMR
spectra were manually phased and referenced to the TSP
signal (δ= - 0.016 ppm at pH 7.4) using Topspin 3.1
(Bruker GmbH, Rheinstetten, Germany). Extraction of a
data matrix for multivariate statistical analysis from the
1H NMR profiles was done using the Statistics toolbox of
AMIX (Bruker Biospin). Spectra were integrated from 0.3
to 10 ppm at a step of 0.01 ppm but excluding the regions
of residual water at 4.68-4.88 ppm. No normalization of
the intensity was performed. The resulting data matrix
contains 947 NMR variables.
Multivariate data analysis: Principal component analy-
sis (PCA) and hierarchical clustering analysis (HCA) were
performed using SIMCA-P 13 (Umetrics, Umea, Sweden)
with scaling based on the Pareto method.
Metabolites identification and quantification: Metabo-
lite identification was achieved by comparing spectra
with databases such as HMDB [66]. Identification of
the metabolites was further verified with homonuclear
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and heteronuclear 2D NMR experiments such as 1H −1
3C HSQC, 1H−1H TOCSY and J-resolved experiments.
Absolute quantification of the metabolites was performed
using Chenomx NMR Suite (Chenomx Inc., Edmonton,
Canada).
Results
Model reconstruction and refinement
Based on the published genomes of 6 strains of M. hyop-
neumoniae, 4 strains of M. hyorhinis and 2 strains of M.
flocculare, we reconstructed 16 genome-scale metabolic
models: one model for each strain separately, one for
each species and a pan-reconstruction for all three species
(Table 1). The semi-automated reconstructions were
manually refined according to the description given in the
“Methods” section.
The Pan-swine Mycoplasma network (representing the
merge of all strains, and called pan-network) was initially
composed by 829 reactions. Duplicate reactions arose
from the fact that Pathway Tools is based only on the
annotations contained in the GenBank files. We removed
generic and duplicate reactions from the models and
replaced them with the specific and validated ones. Non-
metabolic reactions were also excluded at this point, along
with absent capabilities of these mycoplasmas, such as
heme, quinone or cytochrome dependent reactions [67].
The networks were also tested for the presence of DEM
and the ability to produce all biomass precursors. DEMs
were analyzed on a case-by-case manner. From initially
157 DEMs, 124 disconnected metabolites (along with 58
reactions) were excluded from themodels: 14 DEMs came
from 7 spontaneous reactions; 59 were carbohydrate sub-
strates derived from wide range transport reactions and
were not used by any other reaction in the network; 51
were excluded as they did not interfere with the overall
metabolism and/or the enzyme had already been assigned
to one or many other reactions. Orphan reactions were
excluded unless they were essential for biomass growth.
All excluded reactions (non-metabolic, generic, dupli-
cated, orphan) and all DEMs (validated and excluded) are
listed in Additional file 1: Tables S2c and S2d. It is inter-
esting to point out that other unknown enzymes (or even
moonlight enzymes) from these organisms may indeed
use some of the excluded DEMs; however, since we have
no experimental evidence at present, we could not assess
their interference in the metabolic models.
The remaining DEMs consisted mainly of cofactors and
biomass precursors (such as nucleotides, amino acids,
fatty acids) disconnected from the rest of the network.
They were solved along with the biomass precursor check;
141 reactions were added to allow growth: 1 biomass
reaction, 14 enzymatic reactions, 1 drain-synthetic reac-
tion, 105 transport reactions and 5 spontaneous reac-
tions. Transport reactions were considered as such even
if an enzymatic activity was also present (i.e. the import
of sugars with a concomitant phosphorylation of sub-
strate). In order to correctly assign possible and spe-
cific transporters, we performed an extensive literature
search and reciprocal BLAST alignments to characterized
transporters in other species. These results have to be
experimentally confirmed, since assignment of the correct
substrate based only on sequence homology remains an
open problem in genomic annotation.
We also changed inconsistencies of reversibility and
cofactor usage. Even after all efforts, four DEMs still
remained: TTP, hexulose-6-phosphate, deoxyinosine and
xanthosine-5-phosphate. After the final addition of 101
exchange reactions, we ran FBA tests to check the consis-
tency of all models. If a reaction was essential for biomass
growth and no homolog gene was found in the genome,
an orphan reaction was validated or added to the recon-
struction for modeling reasons only. The resulting refined
pan-network had a total of 457 reactions and 258 GPR
associations. A comparison between the species models
may be found in Fig. 1. These results indicate that all
strains from all species are indeed metabolically similar.
The overall characteristics of each reconstruction can
be seen in Table 2. A list of all reactions and metabolites
added to the models along with the corresponding genes
can be seen in Additional file 1: Table S2.
Biomass composition and biomass equation
The biomass equation drained all precursors (in their
molar biological ratios) into biomass. Biomass compo-
sition according to the “Methods” section along with a
detailed description of the assembly of the biomass reac-
tion can be found in Additional file 1: Table S3 and
Additional file 2. Considering the percentage contribution
of each of the components to the overall cell, an approx-
imate biomass elementary composition for M. hyorhi-



















Fig. 1 Venn diagrams representing the comparison of refined
networks. Numbers represent the exclusive and common reactions
present in the refined networks (a) between species, and (b) between
selected strains ofM. hyopneumoniae. This analysis shows that most
of the metabolism is common to all organisms. MHR:M. hyorhinis;
MHP:M. hyopneumoniae; MFL:M. flocculare
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Table 2 Characteristics of reconstructed models from different strains and species












MHP_232 iMF170 170 233 208 111 9 426
MHP_168 iMF172a 172 234 209 111 9 427
MHP_168L iMF172b 172 234 209 111 9 427
MHP_7422 iMF168 168 234 209 111 9 427
MHP_7448 iMF171 171 234 209 111 9 427
MHP_J iMF172c 172 234 209 111 9 427
MHP iMFmhp NA ∗e 234 209 111 9 427
MHR_HUB1 iMF177 177 239 209 111 6 423
MHR_GDL1 iMF175 175 242 210 113 6 426
MHR_SK76 iMF181 181 243 211 113 6 427
MHR_17981 iMF182 182 243 211 113 6 427
MHR iMFmhr NA ∗e 243 211 113 6 427
MFL_27399 iMF159 159 217 196 105 9 401
MFL_27716 iMF157 157 217 196 105 9 401
MFL iMFmfl NA ∗e 217 196 105 9 401
Pan-Network iMFpan NA ∗e 258 230 117 9 457
Notes:
∗a : GPRs are gene-proteins-reaction associations present in each genome. For iMFmhp, iMFmhr, iMFmfl and iMFpan that account for more than one species, we added a GPR
to the species model when any of the strains harbored a gene responsible for a specific activity
∗b : Reactions were considered as transport reactions even if the transporter was capable of performing a concomitant enzymatic activity
∗c : Spontaneous reactions included diffusion of small molecules and spontaneous conversions
∗d : Total number of reactions included also all exchange reactions needed for the mathematical modeling
∗e : Genes in the pan-network and species models were added synthetically (one per reaction), to enable a reaction essentiality analysis
with traces of calcium, chlorum, cobalt, copper, iron,
potassium, magnesium, manganese, molibdenium and
zync and molecular weight (MW) on a C-mole basis
of 23.89 g/C − mol. We had a slightly different com-
position for M. hyopneumoniae and M. flocculare:
CH1.59O0.34N0.21P0.16S0.02, with the previously mentioned
trace compounds and MW on a C-mole basis of 23.31
g/C − mol.
Metabolism ofM. hyorhinis,M. hyopneumoniae andM.
flocculare
Similar to most Mycoplasma species studied so far
[46–48], all reconstructed networks exhibit low connec-
tivity due to the simplicity of the biological model. Out
of the 457 reactions in the final pan-network, 258 had
in at least one species a GPR association. From these,
212 were common to all species (Fig. 1). The overall
metabolism from the models reconstructed consisted of
11 distinct subsystems: amino sugar metabolism, amino
acid metabolism, carbohydrate metabolism (further bro-
ken down into: glycolysis, pentose phosphate pathway,
ascorbate degradation, myo-inositol degradation, gen-
eral carbohydrate metabolism, and pyruvate metabolism),
cofactor metabolism, lipid metabolism, and nucleotide
metabolism (Fig. 2 for pan-network; the number of GPR
associations for each species can be seen in Additional
file 1: Tables S4a and S4b). While all enzymes were
present in glycolysis, most metabolic pathways had major
enzyme gaps. In the product and cofactor metabolism,
for instance, gaps accounted for up to 50 % of the reac-
tions.M. flocculare was the only species that did not show
any exclusive metabolic activities in the models, although
this could not be verified in vivo due to lack of biochem-
ical studies for this species. M. hyopneumoniae had 10
exclusive reactions, linked to themyo-inositol metabolism
and alcohol dehydrogenase activity. M. hyorhinis had 24
exclusive reactions; most of them corresponded to car-
bohydrate metabolism. A global model comparing each
species enzymatic capabilities can be seen in Figs. 3 and
4. The complete list of metabolite abbreviations and EC
numbers for these two figures can be found in Additional
file 3.
Transporters
Transporter assignment was made in silico based
on sequence similarity to known transporters. We
were able to identify in all species complete putative
ABC transporters for multidrug/toxin efflux and for
import of sugars, oligopeptides, peptides, spermidine/
putrescine, phosphonate/phosphate/thiamine, cobalt,
manganese/zinc and glycerol. In the search of a
possible nucleotide transporter, we came across with
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Fig. 2 Distribution of the model reactions in the subsystems. The 457 reactions present in the model iMFpan were separated into (a) biological
subsystems and (b) further into reaction types, with the exclusion of exchange reactions in this analysis
an unpublished work from Lee [68] in which a system
previously annotated as sugar ABC transporter was
experimentally validated as involved in nucleoside uptake
in Mycoplasma bovis. These results may be highly spec-
ulative, and need further verification, but we were able
to find homolog genes in the genomes of all species. M.
hyopneumoniae seems to have an extra ABC transporter
proposed for myo-inositol and M. hyorhinis has a unique
predicted ABC transporter for maltose/maltodextrins.
Three complete phospho-transferase transport systems
(PTS) were common to all species. Although specificity
of PTS is difficult to ascertain, we have tried to compare
conserved domains from validated PTS substrate-specific
enzymes II (available in TransportDB [69]) and candi-
dates from the three species. Genes coding enzyme I
and phosphocarrier were found in all strains, except in
MHR_HUB1. From sequence similarity and gene context
we were able to annotate the correct gene. Based on these
in silico predictions from domain retrieval, we propose
the following: one PTS non-specific for sugar, one with
specificity for fructose and another for mannitol. M.
hyopneumoniae and M. flocculare also share two extra
complete systems: one possibly for ascorbate and one
for N-acetylglucosamine (GlcNAc). M. hyorhinis and M.
hyopneumoniae seem to have an extra IIB component
specific for glucose, and along with the other compo-
nents of the general sugar PTS were proposed to form a
complete glucose PTS.
The protein GlpU, coded by gene MPN241 in M. pneu-
moniae, was recently described to act on the uptake of
glycerophosphodiesters [70]. We found homologs of this
gene in all strains of M. hyopneumoniae and M. hyorhi-
nis adjacent to the gene coding for the enzyme responsible
for the metabolization of these substrates (GlpQ) [71]. In
MHR_HUB1, this gene was annotated as a pseudo gene,
but from gene context, we were able to validate it as
GlpU. All species also possess several unspecific amino
acid permeases, a glycerol facilitator protein (GlyF), which
is thought to be less efficient than the glycerol ABC
transporter (ABC-Gly) [35]) and a major facilitator pro-
tein (MIF) with unknown specificity . We could also find
common transporters for cobalt and magnesium, chro-
mate, magnesium, potassium, zinc and a cation ATPase.
M. hyorhinis has two extra transport systems: one for
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Fig. 3 Global energy and carbohydrate complete models. Metabolites are depicted in dark green and separate enzymatic activities forM. hyorhinis,
M. hyopneumoniae andM. flocculare can be seen in yellow, pink and blue, respectively. Whenever an enzyme is missing from the three species, the
enzyme rectangle is depicted in grey. Complete list of metabolite abbreviations and EC numbers can be found in Additional file 4
sialic acid (also known as N-acetyl neuraminate) and one
sodium/phosphate co-transporter. Details of the trans-
port search throughout all species is summarized in
Additional file 4.
Carbohydrate and energymetabolism
Glycolysis As previously described in [18], all genes for
the glycolysis exist in all strains of all species.M. hyorhinis
may be able to convert dihydroxyacetone (DHA) directly
to dihydroxyacetone-phosphate (DHAP) with the action
of DHA kinase (2.7.1.29), but the mechanism of DHA
uptake is not clear.
Pentose Phosphate In agreement with previously
described literature [14, 18, 72], we found no enzymes for
the oxidative branch of the pentose phosphate pathway in
the studied species, turning ribulose-5-phosphate into a
DEM. This problem was overcome by the assumption that
the reaction ribulose-phosphate-3-epimerase (EC 5.1.3.1)
can be reversible, as reported in Lactobacillus casei [73].
Out of the 11 reactions present in the final models, we
found homologs for 9 in all species. Although a gene cod-
ing for transaldolase (EC 2.2.1.2) is missing in all species,
we included this reaction in the models to prevent both
sedoheptulose-7-phosphate and erithrose-4-phosphate
from becoming DEM.
Ascorbate Metabolism Only one enzyme is missing
from the typical pathway: L-ascorbate-6-phosphate-
lactonase (UlaG). This enzyme is responsible for the
turnover of L-ascorbate-6-phosphate to 3-keto-gulonate-
6-phosphate (EC 3.1.1.-). From the gene context,
MHP_7448_0377 from MHP_7448 and its homologs
from all other organisms may encode the missing enzyme.
The gene was annotated as a conserved hypothetical
protein with a proposed phosphotriesterase activity.
Uptake of other carbohydrates While the uptake of
fructose, mannitol and mannose is similar in all species
and they all can be fed into glycolysis as fructose-6-
phosphate (F6P) and DHAP, M. hyorhinis has an extra
set of enzymes enabling the conversion of fructose-1-
phosphate into fructose-1,6-biphosphate by the action of
1-phosphofructokinase (EC 2.7.1.56). Only in M. hyop-
neumoniae the conversion of glyceraldehyde into glycerol
might be possible through the moonlight activity of alco-
hol dehydrogenase (EC 1.1.1.372), although up to date
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Fig. 4 Lipid, amino acid, nucleotide and cofactor complete models. Metabolites are depicted in dark green and separate enzymatic activities forM.
hyorhinis,M. hyopneumoniae andM. flocculare can be seen in yellow, pink and blue, respectively. Whenever an enzyme is missing from the three
species, the enzyme rectangle is depicted in grey. Complete list of metabolite abbreviations and EC numbers can be found in Additional file 4
no experimental evidence can sustain that assumption.
The presence of a unique transcriptional unit (TU) with
carbohydrate metabolism-related genes in M. hyorhinis
probably enables the uptake and metabolization of iso-
maltose (EC 3.2.1.10), maltose (EC 2.4.1.8), trehalose (EC
2.4.1.64 and EC 3.2.1.93) and sucrose (EC 3.2.1.48) into
either glucose-6-phosphate or F6P. This may be related
to the fact that M. hyorhinis can overgrow the other two
species in several growth media.
Myo-inositol metabolism A TU for the myo-inositol
catabolism is present in all M. hyopneumoniae strains,
with the exception of the enzyme 5-dehydro-2-deoxy-
phosphogluconate aldolase (IolJ, EC 4.1.2.29). The gene
encoding this enzyme in other organisms is similar to the
fructose-biphosphate aldolase (Fba) from glycolysis (EC
4.1.2.13). Since there are two copies annotated for Fba in
M. hyopneumoniae, we proposed one of them as candi-
date for this activity based on sequence alignments with
both genes from Bacillus subtilis. Inositol can be used
as a carbon source and also produces acetyl coenzyme-A
(AcCoA), which can be a source of cofactor coenzyme-A
(CoA).
Amino sugar metabolism M. hyopneumoniae and M.
floccularemodels could uptake and convert GlcNAc to N-
acetyl-glucosamine-6-phosphate (GlcNAc6P); M. hyorhi-
nis models imported sialic acid and converted it to
GlcNAc6P in three steps that are unique to M. hyorhi-
nis (EC 4.1.3.3, EC 2.7.1.60, EC 5.1.3.9). At first, the
genes coding for these three enzymes were absent from
MHR_HUB1 and MHR_GDL1. However, based on chro-
mosome alignment and synteny with other genes, we were
able to find the regions and correctly annotate all genes.
Pyruvatemetabolism Out of fifteen enzymatic reactions
in this pathway, only three were not found in any organ-
ism. Conversion of pyruvate to lactate and acetate were
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possible in all species. From literature data, we knew
that M. hyopneumoniae was able to produce oxaloac-
etate, malate and 2-oxoglutarate (2KG) [74, 75]. Decar-
boxylation of 2KG to succinyl coenzyme-A (SucCoA) has
been previously reported in M. hyorhinis extracts [76].
Although we did not find any candidate for the activity of
aspartate transaminase (EC 2.6.1.1), gap-filling proposed
that this activity could be performed by the pyruvate
dehydrogenase complex. Moreover, Cordwell and collab-
orators [77] suggested that in Mollicutes lactate dehydro-
genase (Ldh, EC 1.1.1.27) could also function as malate
dehydrogenase (Mdh, EC 1.1.1.37). M. hyopneumoniae is
the only organism among the three to have a gene cod-
ing for an alcohol dehydrogenase, probably enabling the
turnover of AcCoA to acetaldehyde (EC 1.2.1.1 0) and
ethanol (EC 1.1.1.1). Conversion of pyruvate to formate by
pyruvate formate-lyase (EC 2.3.1.54), malate to fumarate
by fumarate hydratase (EC 4.2.1.2) and SucCoA to succi-
nate by succinyl-CoA synthetase (EC 6.2.1.5) were added
to the models in a final step to accommodate the results
from the metabolomics experiments.
Lipidmetabolism
The lipid metabolism in the models of the three
species included the uptake of glycerol, choline, glyc-
erophosphodiesters and fatty acids to the production
of the biomass precursors cardiolipin, 1,2-diacyl-sn-
glycerol, phosphatidylglycerol, phosphatidylcholine and
galactosyl-diacylglycerols (except in M. hyorhinis). Extra-
cellular cholesterol and sphyngomyelin were incorporated
unmodified directly into biomass. While M. hyopneumo-
niae seems to have four different ways to uptake and
metabolize glycerol (ABC-Gly, GlyF, GlpU and directly
from glyceraldehyde) M. hyorhinis lacks one and M.
flocculare lacks two of them (Fig. 4). The turnover of
glycerol-3-phosphate into DHAP by the action of glycerol-
3-phosphate oxidase (GlpO, EC 1.1.3.21) allows the usage
of glycerol as the sole carbon source, with the production
of highly toxic hydrogen peroxide. This was only possible
in theM. hyorhinis andM. hyopneumoniaemodels.
The enzyme responsible for the turnover of glycerol-
3-phosphate into acyl-sn-glycerol-3-phosphate (glycerol-
3-phosphate 1-O-acyltransferase, EC 2.3.1.15) was found
only in the genomes of M. hyorhinis. Although this can
be seen as a possible difference between the species,
we had to add the reaction to the models from the
other species to enable growth. It is possible that the
other two species import this metabolite directly from
the media, however further experiments are required to
confirm this hypothesis. No homologs for the enzyme
that produces phosphatidylglycerol (phosphatidylglyc-
erophosphatase, EC 3.1.3.27) were found; however, all
Mollicutes definitely synthesize this metabolite, and hence
must use a hitherto undetected enzyme for this step [78].
The acyl-carrier protein (ACP) was only found in the
genomes of M. hyorhinis and may act as a fatty acid and
CoA donor in these organisms. Orphan reactions for the
production of glycolipids (EC 2.4.1.46 and EC 2.4.1.241)
were added to models for M. hyopneumoniae andM. floc-
culare based on the presence of these metabolites in
vivo [56].
Amino acidmetabolism
The import of amino acids was added in two forms:
oligopeptide import and cleavage or single amino acid
import. tRNA charging accounts for most of the reac-
tions in this pathway (23 reactions). Production of
the biomass precursor S-adenosyl-methionine from
methionine is possible in all strains (methionine adeno-
syltransferase, EC 2.5.1.5). Moreover, since the enzyme
adenosylhomocysteine nucleosidase (EC 3.2.2.9) is
present in all species, we added two reactions to restore
connectivity between these two subpathways (EC 2.1.1.-
and EC 4.4.1.21). This addition resulted in the production
of two metabolites essential for quorum sensing and cell
communication in other species: S-rybosyl-homocysteine
and autoinducer-2.
Nucleotidemetabolism
The mycoplasmas in this study cannot synthesize de novo
purines and pyrimidines; therefore, they have only sal-
vage pathways and interconversions to supply the cell
with nucleic acid precursors. The three species have
the same enzymatic capabilities, except for the presence
of thymidylate synthetase (EC 2.1.1.46) in M. hyorhi-
nis, which is also important for cofactor metabolism and
is responsible for the conversion of dUMP and 5,10-
methylene-tetrahydrofolate (MeTHF) to dTMP and dihy-
drofolate. Overall, the nucleotide metabolism consists
in the uptake of guanine, adenine, uracil, thymine and
cytidine and produces all deoxy-ribonucleotides (dATP,
dCTP, dGTP, TTP) and ribonucleotides (ATP, CTP, GTP
and UTP).
Cofactormetabolism
Around 60 % of the enzymes that comprise the cofactor
metabolism of the reconstructed models were not found
in any species. For instance, thiamine-pyrophosphate
is imported unchanged directly into biomass, while
pyridoxal is imported and converted to the cofac-
tors pyridoxal-phosphate by the action of pyridoxal
kinase (EC 2.7.1.36 missing in all species). From the
pantothenate/coenzyme-A metabolism, we only found
homologs for the conversion of 4’-phosphopantetheine
into dephospho-coenzyme-A by pantetheine-phosphate
adenylyltransferase (EC 2.7.7.3). Three forms of folate
are incorporated to the biomass: MeTHF, 5,6,7,8-tetra-
hydrofolate and 10-formyl-tetra-hydrofolate. We assumed
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that folate was imported and converted to these three
biomass cofactors by: dihydrofolate reductase (EC 1.5.1.3,
only present inM. hyorhinis), serine hydroxymethyltrans-
ferase (EC 2.1.2.1, present in all species) and formate-
tetrahydrofolate ligase (EC 6.3.4.3, missing in all species).
This may also account for the better fitness of M. hyorhi-
nis when compared to the other two species. Although no
homologs for NAD kinase were found, two reactions were
added (EC 2.7.1.23 and EC 2.7.1.86) to allow the presence
of NADP and NADPH, which are cofactors for several
essential reactions. The NADPH and NADH produced
from the degradation of glucose and other carbohydrates
are recycled by the action of two enzymes: NADH oxidase
(hydrogen peroxide forming, EC 1.6.3.3) and thioredoxin
disulfide-reductase (EC 1.8.1.9).
Mycoplasmas cultivation
We cultivated the three species of mycoplasmas in com-
plex and defined media to gather experimental infor-
mation and compare to in silico growth (Fig. 5). In
the CMRL+ medium, M. hyopneumoniae and M. floc-
culare remained viable only when peptone was present
(CMRL+/Pep). The presence of peptone appeared to
have a negative effect on M. hyorhinis growth, but more
tests should be performed to verify this hypothesis. Yus+
medium did not allow proliferation in any species, but
maintained cell concentration and viability even after
5 days of culture (if inoculated afterwards in complex
media). These results are in agreement with a previ-
ous work performed by Bertin and colleagues [79] in M.
mycoides subsp. mycoides that shows that CMRL-1066
contains all components to support cellular metabolism
but not growth. Here, the supplemented versions CMRL+
or CMRL+/Pep allowed proliferation only for M. hyorhi-
nis during the first 24 h of growth. It seems that after
this period of time, one or more essential metabolites ini-
tially present were no longer available. By comparing the
models reconstructed in this work with the media compo-
sition tested for the three species, it might seem plausible
that key cofactors might not be delivered to mycoplasmas
in the correct form. For example, thiamine pyrophos-
phate should be directly delivered to all species instead of
its precursor thiamine, and pyridoxal-5-phosphate might
be the cofactor of choice for the media composition in
place of pyridoxal. A list of predicted biomass precursors
from the models versus the actual precursors found in the
Yus+ medium can be seen in Additional file 1: Table S5.
This new proposed defined medium will be submitted in
the near future to cultivation tests with M. hyorhinis, M.
hyopneumoniae andM. flocculare.
Metabolomics of swine mycoplasma
NMR analysis of the culture media was performed in
order to detect possible differences in the metabolism of
the three species. All data measured in defined and com-
plex media can be seen in Additional file 1: Tables S6a
and S6b.
The major differences in both complex and defined
media were related to the metabolism of pyruvate (Fig. 6):
M. hyorhinis produced higher quantities of pyruvate at the
end of 48 h in complex medium. As a result, pyruvate con-
version to acetate was detected in low quantities for this
species in both media. M. hyopneumoniae and M. floc-
culare, on the other hand, produced higher amounts of
acetate (this was even more pronounced for the growth
ofM. hyopneumoniae in complex medium). Low amounts
Fig. 5 Cultivation curves in defined and complex media by species. Cell concentrations were estimated by the CCU method and error bars were
calculated as the standard deviation between triplicate time-matched samples. As expected, the three species had better growth rates in the
complex medium than in defined media.M. hyopneumoniae strain J (MHP);M. flocculare strain 27716 (MFL);M. hyorhinis strain ATCC17981 (MHR)
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Fig. 6 Distinct products of the metabolism of pyruvate from growth in complex Friis medium and Yus+ medium ofM. hyopneumoniae strains 7448
(MHP_7448) and J (MHP_J),M. flocculare strain 27716 (MFL_27716) andM. hyorhinis strain ATCC17981 (MHR_17981). In complex medium, we
calculated the ratio between the peak signal in cultivated versus control medium and error bars were calculated as the standard deviation between
triplicate time-matched samples. For defined medium, we detected the actual concentration for the metabolites and error bars were calculated as
the standard deviation between duplicate time-matched samples. a In complex medium,M. hyopneumoniae (both strains) andM. flocculare can
produce high amounts of acetate; the yields are even higher fromM. hyopneumoniae.M. hyorhinis, on the other hand, produces low concentrations
of acetate in this medium. The final glycolysis product forM. hyorhinis is thus pyruvate. b In defined medium,M. hyopneumoniae (strain J) andM.
flocculare produce similar amounts of acetate whileM. hyorhinis contains only residual levels of this metabolite. The three species can produce low
amounts of formate in both media
of formate, fumarate and succinate were also detected,
and this indicates the presence of genes encoding the
enzymes pyruvate formate-lyase (EC 2.3.1.54), fumarate
hydratase (EC 4.2.1.2) and succinyl-CoA synthetase (EC
6.2.1.5) in these genomes. As previously mentioned, all
models were thus modified to accommodate these activ-
ities. Formate production seems to be independent from
acetate production in M. hyopneumoniae and M. floccu-
lare. However, the similar low concentrations of acetate
and formate in both growth media from M. hyorhinis
might be an indication that both are produced con-
comitantly by the action of pyruvate formate-lyase (EC
2.3.1.54), phosphate acetyl-trasnferase (EC 2.3.1.8) and
acetate kinase (EC 2.7.2.1).
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To check if the lower concentrations of acetate were
a result of an impaired activity of the pyruvate dehy-
drogenase complex in M. hyorhinis, we compared the
predicted proteins PdhA, PdhB, PdhC and PdhD from
all species. The known active sites of ODP2 (homolog of
PdhC) and OLDH1 (homologs to PdhC and PdhD respec-
tively) from Bacillus subtilis were analyzed in search for
a possible mutation. No active sites have been described
for PdhA and PdhB so far, but the enzymes for all three
swine mycoplasmas do not present significant differences.
Although not all active sites from PdhD seem to exist in
mycoplasmas, all predicted proteins from the species ana-
lyzed (including M. genitalium and M. pneumoniae) are
similar in terms of active sites, when these are present.
The only difference between M. hyorhinis and the other
two species was found in PdhC, in the protein portion
related to the binding to PdhA and PdhD. This portion is
the most variable between the species. An enzyme charac-
terization should bemade in order to verify if this complex
is not active in this species, or if it is responsible for
another unforeseen activity.
The presence of myo-inositol in swine serum [80] might
be directly related to the higher production of acetate in
the growth of M. hyopneumoniae in complex medium, if
compared to M. flocculare. Since the myo-inositol path-
way produces AcCoA, the recovery of a molecule of CoA
frommyo-inositol is possible andmay be directly linked to
the production of acetate. Since themyo-inositol catabolic
pathway is one of the few distinctions between the
metabolic models of M. hyopneumoniae and M. floccu-
lare, it is possible to assume that the differences in acetate
concentration in vitro may indeed arise from the ability of
M. hyopneumoniae to uptake myo-inositol. Indeed, when
no source of myo-inositol is present (defined medium), no
difference in the concentration of acetate is observed for
these two species.
The analysis of the amino acid uptake was not triv-
ial since both media contained peptone, which at first
was not measured through the CPMG experiment but,
in the course of time, was degraded into single amino
acids, and thus changed the overall signal of the NMR
spectra. To address this issue, we only took into account
the Yus+ medium at a single time point after 72 h of
growth. M. hyorhinis seemed to have lower concentra-
tions of most amino acids at the end of the growth curve
if compared either to the control medium or to the other
species. This may be related to several factors, such as
lower rates (in comparison to the other two species) of
peptone degradation by membrane proteases or higher
uptake rates of amino acids byM. hyorhinis. At this point,
we could no longer verify which hypothesis is more suit-
able for this particular distinction, however, since peptone
was not necessary for the maintenance of the viability of
M. hyorhinis in the defined medium, it is possible that this
species may harbor transporters with higher specificity or
effectiveness for single amino acids.
The results as concerns the other metabolites indi-
cate for the three species the uptake of glucose and
nucleotides.
Flux balance analysis (FBA)
FBA was used to check the properties and capabilities
to produce detected metabolites by NMR spectra of all
models (also during the reconstruction and refinement
process). FBA simulations were performed with an in
silicomedium that contained all biomass precursors. Sim-
ilarly to the in vitro growth results, in the presence of
oxygen, acetate was the main product and NADH was
recycled by the conversion ofmolecular oxygen into water.
In the absence of oxygen (not tested in vitro), all models
were able to grow but the main product became lactate.
As expected, the availability of myo-inositol in the in sil-
ico medium allowed an alternative source of CoA and
higher concentrations of acetate as a final product in the
models for M. hyopneumoniae. Hydrogen peroxide pro-
duction was linked to the metabolism of glycerol in both
M. hyopneumoniae andM. hyorhinis, while the models for
M. flocculare did not produce toxic levels of this metabo-
lite. Since we have no information on gene essentiality for
any species, we checked reaction essentiality in the pan-
network. This means that we deleted individual reactions
(all transport, enzymatic and spontaneous reactions) even
if they did not have a GPR association. A total of 111
reactions (69 enzymatic, 37 transport, and 5 spontaneous
reactions) were essential for growth in the pan-network
(Additional file 1: Table S7).
Discussion
In this work, we created a metabolism as realistic as pos-
sible for the three known mycoplasmas present in the
respiratory tract of swine. It is essential to point out that,
although we had to include 30 % of orphan reactions in
order to allow growth, we only used about half of the
genomes of these organisms. The other half consists either
of hypothetical or of conserved hypothetical proteins [18],
which may in part fill the missing gaps of the models. The
number of essential reactions in the pan-network in this
work is not directly comparable to the number of indis-
pensable genes predicted for M. genitalium (382 genes)
or M. pneumoniae (310 genes) [81, 82]. Gene essentiality
accounts for more than metabolic enzymes which means
that proteins not included in our models, related to pro-
tein synthesis, DNA polymerization or RNA turnover,
were not accounted for in the essential reactions of our
models. If we added these proteins, we would possibly
arrive at numbers closer to those of M. genitalium and
M. pneumoniae. The lack of experimental information on
gene essentiality is also a setback for the validation of the
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models created here. Further experiments on this matter
should help us better refine and complete the networks.
As for most of theMycoplasma species studied [46–48],
all reconstructed networks exhibit low connectivity due
to the simplicity of the biological model. We were able
to show in this work that the three swine mycoplasma
species have similar metabolic capabilities, except for the
metabolism of myo-inositol, amino sugar, carbohydrates
and glycerol (Fig. 7). Overall, the methods used here
enabled us to address some of the main problems caused
by most automatic reconstruction methods which are the
permissive inclusion of pathways and over prediction of
capabilities. Annotation errors arise with the attribution
of ambiguous or partial EC numbers [83, 84] and the
propagation of these errors may then lead to many other
ones. Thus, it is known that the prediction of GPR asso-
ciations based only on name-matching and EC-codes is
not sufficient to add confidence to a model [84]. When
we decided to simultaneously refine the 12 models, we
enhanced the confidence of each GPR association, by
adding information on the synteny between the genomes,
protein sequence alignments and phylogenetic distance
between orthologs.
Our main objective was not only to reconstruct the
metabolic models for M. hyorhinis, M. hyopneumoniae
and M. flocculare. We also wanted to compare the
metabolism of the three species and find possible links
to virulence, host-colonization capacity and life-style. M.
hyorhinis, for instance, is not only a pathogen, but also a
common contaminant in many mammalian cell cultures
[85]. This may be explained by the wide range of carbo-
hydrates which this organism can uptake and metabolize.
Thismay be a crucial factor to the ability ofM. hyorhinis to
grow in diverse sites inside the host [7] and even to invade
other hosts and potentially develop cancer in humans
[58, 86]. M. hyopneumoniae has been detected in other
sites such as brain, liver and spleen [87, 88], but M. floc-
culare has never been detected outside of the respiratory
tract of swine.
One may wonder what could explain this if both organ-
isms are so similar. M. hyopneumoniae is up to date the
only Mycoplasma species with sequenced genome that
has the genes for the catabolism of myo-inositol. Myo-
inositol is readily abundant in the bloodstream of mam-
malian hosts, and can be used as a secondary carbon
source for energy production [89]. Mycoplasma iguanae
has been described to produce acid from inositol [90].
However, there is no available complete genome sequence
for this organism, making impossible any comparison of
the genes involved in this pathway. Although at this point
we cannot confirm that this pathway is functional in M.
hyopneumoniae, the NMR results we obtained suggest
Fig. 7 Differential metabolism ofM. hyorhinis,M. hyopneumoniae andM. flocculare. Metabolites are depicted in dark green and separate enzymatic
activities forM. hyorhinis,M. hyopneumoniae andM. flocculare can be seen in yellow, pink and blue, respectively. Whenever an enzyme is missing from
the three species, the enzyme rectangle is depicted in grey. Complete list of metabolite abbreviations and EC numbers can be found in
Additional file 4
Ferrarini et al. BMC Genomics  (2016) 17:353 Page 16 of 20
that myo-inositol might be directly related to the higher
production of acetate in complex medium ofM. hyopneu-
moniae if compared to M. flocculare. This assumption is
based on two factors: first, a previous work has detected
myo-inositol in swine serum, which is a component of
the complex medium [80]; and second, the only difference
in the networks that could influence the acetate concen-
tration is the myo-inositol catabolism. This pathway may
also be involved with an alternative production of AcCoA,
precursor to CoA, an essential cofactor for growth in
all species. These metabolic distinctions may help M.
hyopneumoniae to grow in diverse sites if compared to
M. flocculare. This is particularly interesting when we
take a close look into the composition of lung surfactant
from several mammalian models [91], which likely con-
tains myo-inositol as a degradation product from phos-
phatidylinositol. Thus, it is possible that the myo-inositol
catabolism inM. hyopneumoniae is one of the reasons for
the high virulence of this species when compared to M.
flocculare andM. hyorhinis.
A striking result from the NMR results was the reduced
capability of M. hyorhinis to produce acetate. This was
not foreseen in the model reconstruction, but predicted
protein sequences from the pyruvate dehydrogenase com-
plex of the three species showed a particular distinction in
PdhC, more specifically in the region responsible for bind-
ing to other complex components. We could not verify
at this point if this complex is not active in the particu-
lar growth conditions of our work in M. hyorhinis or if
it is responsible for another unforeseen activity. However,
a transcriptome profiling of M. hyorhinis has detected
both pdhA and pdhB in the pool of genes with the high-
est number of transcript reads [32], indicating that the
complex might be translated in vivo. Moreover, pyruvate
dehydrogenase activity has been previously detected inM.
hyorhinis extracts [75], and it seems to be correlated to
oxygen availability. In our cultivations, the cells are not
grown in a complete aerobic system, which may explain
the differences between our findings and those previously
published.
Cultivation tests in vitro also showed that none of
the species was able to grow in none of the defined
media. This is probably due to a lack of the cor-
rect cofactors as previously mentioned. For instance,
thiamine, pyridoxal/pyridoxine, pantothenate, spermine
and folate were the actual media components tested,
but the reconstructed models were not able to convert
them to biomass precursors (thiamine pyrophosphate,
pyridoxal-5-phosphate, 4-phospho-pantheteine, spermi-
dine and THF). Only M. hyorhinis seems to be able to
uptake folate directly while the other two species might
need intermediate metabolites. This might also explain
why M. hyorhinis is extensively found as a cell culture
contaminant. Even though we supplemented CMRL-1066
(CMRL+) with all missing components present in the
Yus+medium, cells maintained viability for longer periods
in the latter. Cofactors present originally in both media
existed in lower concentrations in the CMRL-1066. This
means that possibly one or more cofactors with higher
concentrations in the Yus+ medium are essential for the
viability of the three species. Common cofactors with
higher concentration in Yus+ medium included: choline,
folate, pantothenate, pyridoxal, thiamine and spermine.
Other differences among the species seem to indicate
that M. hyopneumoniae and M. flocculare lack one or
more amino acid transporters. This may be due to two
things: (i) both remained viable for longer periods when-
ever CMRL+ was supplemented with peptone, and (ii)
we detected a higher amino acid accumulation in the
defined media if compared to M. hyorhinis. M. hyorhinis
on the other hand may have all the transporters for sin-
gle amino acids, but this hypothesis needs to be further
verified. From sequence analyses, we did not find signifi-
cant differences among the species that would explain this
distinct behavior. Moreover, since M. hyorhinis seemed
to overgrow in the first 24 h of culture in both CMRL
media (CMRL+ and CMRL+/Pep), it is possible that one
or more compounds were missing in the Yus+ medium in
order to allow growth of this species. Possible candidates
for such (present in CMRL-1066 and absent in the Yus+
medium) would be: CoA, nicotinamide, ascorbate and/or
pyridoxine.
It is still not clear if any of the swine mycoplas-
mas studied here indeed have a polysaccharide capsule,
given that only one study has assesed its presence in
M. hyopneumoniae. However, this is particularly impor-
tant because in this study Tajima and Yagihashi [28], as
discussed before, reported that capsular polysaccharides
from M. hyopneumoniae play a key role in the interac-
tion between pathogen and host. Moreover, it has been
reported that some strains of M. hyopneumoniae become
less pathogenic in broth culture and, after serial passages,
lose their ability to produce gross pneumonia in pigs [26].
In several bacterial species, it has been established that
the amount of capsular polysaccharide is a major factor in
virulence [92] and it decreases significantly with in vitro
passages [93]. Furthermore, despite increasing evidence
supporting the existence of a polysaccharide capsule in
several Mycoplasma species, it is not yet known if the
material is synthesized by the bacteria or imported from
the medium for most species [94]. Recent reports have
even shown the capacity of species from the mycoides
cluster to assemble a capsule from exogenous phospho-
rylated glucose [79, 95]. However, no homolog proteins
related to these activities were found in none of the species
studied in this work. For the reasons discussed above, we
were not able to introduce the capsule production itself
in the models; however, we tried to relate its possible
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existence with the substrates that might be used to pro-
duce it. The composition of capsular polysaccharides has
been related to the level of pathogenicity in other bacteria.
For instance, highly virulent Escherichia coli strains seem
to have practically nonimmunogenic capsular material,
due to the fact that these antigens are similar or identical
to the ones found in the host [96]. The structure of the K5
antigen from E. coli capsules is basically GlcNAc and glu-
curonic acid (GlcA) in a molar ratio of 1:1 [97]. Erlinger
and collaborators [98] identified heparan sulfate (HS) as
the predominant glycosaminoglycan in the porcine res-
piratory tract and the most common disaccharide unit
within HS is GlcNAc linked to GlcA. Since M. hyopneu-
moniae andM. floccularemight be able to import GlcNAc
unchanged, they may use it for the composition of its cap-
sule; M. hyorhinis, on the other hand, imports sialic acid,
and might use it directly to produce its own. Of course
this is highly speculative, and we are not sure if all these
hypotheses indeed happen in vivo.
The metabolism of glycerol is the final major differ-
ence between the pathogenic M. hyopneumoniae and M.
hyorhinis and the non-pathogenic M. flocculare. Such
metabolism and the production of hydrogen peroxide by
the action of GlpO are essential for the cytotoxicity of
M. pneumoniae [35] and M. mycoides subsp. mycoides
[36]. Particularly, the cytotoxicity of M. mycoides subsp.
mycoides is due to the translocation of the hydrogen per-
oxide into the host cells. This is only possible because
of the close proximity to the host cells along with the
membrane-bound enzyme. Highly conserved homolog
genes to this enzyme were only found in the genomes of
the pathogenic species studied here. Whether or not these
enzymes from M. hyopneumoniae and M. hyorhinis are
indeed capable of the same activities as GlpO is not yet
confirmed; however, the high similarity may be an indica-
tion that this trait is essential for the pathogenicity of these
two species. This may also explain why both M. hyop-
neumoniae and M. flocculare can adhere to the cilia of
tracheal epithelial cells, but only the adhesion ofM. hyop-
neumoniae results in tissue damage [33]. Moreover, while
M. hyorhinis has in the reconstructed models three ways
of uptaking glycerol, M. hyopneumoniae seems to have
five, and this may reflect in its enhanced pathogenicity.
Conclusions
We presented in this work an overview of the differ-
ential metabolism of M. hyopneumoniae, M. hyorhinis
and M. flocculare using different approaches. The recon-
structed models showed some distinctions among the
species, namely the myo-inositol metabolism forM. hyop-
neumoniae, the wider uptake of carbohydrates for M.
hyorhinis and the usage of glycerol as a carbon source for
the two pathogenic species. The models also served as a
basis for all the assumptions made for the experimental
data. Metabolic profiling of both complex and defined
media pointed to new differences that we were not able
to identify based solely on the sequenced genomes. The
major ones were related to the pyruvate conversion to
acetate, which appeared to be higher in M. hyopneumo-
niae and M. flocculare than in M. hyorhinis. After we
performed growth tests using defined media that hypo-
thetically would lead to bacterial growth in silico, we
assessed that some cofactors or metabolites were proba-
bly being delivered in the wrong form to themycoplasmas.
The environmental context may explain the differences
between the in silicomodels and the in vivo behavior.
Whether the main differences among the species we
reported here (summarized in Additional file 1: Table S8)
are related to virulence or pathogenicity have not yet been
addressed experimentally, but it is tempting to speculate.
The same factors that may enhance virulence of M. hyop-
neumoniaemay help the commensal speciesM. flocculare
to better survive inside the host.
All these in silico and in vivo metabolic differences
among M. hyopneumoniae, M. hyorhinis and M. floccu-
lare might influence the different levels of pathogenicity
in each of them. However, it is highly likely that gene
regulation may directly interfere in the metabolism and
pathogenicity and may be related to many other aspects
still unaccounted for. One of our future goals is there-
fore to understand and integrate gene regulation into the
metabolic models. Upcoming experiments will aim at test-
ing the hypotheses formulated here, particularly those
related to the metabolisms of glycerol and myo-inositol.
We also intend to better understand the habitat of these
species, and the possible metabolic and genetic dialogues
with the host and other bacteria present in this environ-
ment. Either way, this work serves as a basis for the study
of the differential metabolism and pathologies caused by
the swine lung mycoplasmas and may help to propose
ways to prevent disease development in the future.
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